138 related articles for article (PubMed ID: 16204436)
21. Posttraumatic stress disorder, gender, and problem profiles in substance dependent patients.
Peirce JM; Kindbom KA; Waesche MC; Yuscavage AS; Brooner RK
Subst Use Misuse; 2008; 43(5):596-611. PubMed ID: 18393079
[TBL] [Abstract][Full Text] [Related]
22. Application of BRCA1 and BRCA2 mutation carrier prediction models in breast and/or ovarian cancer families of French Canadian descent.
Oros KK; Ghadirian P; Maugard CM; Perret C; Paredes Y; Mes-Masson AM; Foulkes WD; Provencher D; Tonin PN
Clin Genet; 2006 Oct; 70(4):320-9. PubMed ID: 16965326
[TBL] [Abstract][Full Text] [Related]
23. Direct-to-patient BRCA1 testing: the Twoj Styl experience.
Gronwald J; Huzarski T; Byrski T; Debniak T; Metcalfe K; Narod SA; Lubiński J
Breast Cancer Res Treat; 2006 Dec; 100(3):239-45. PubMed ID: 16807675
[TBL] [Abstract][Full Text] [Related]
24. Comparison of proactive and usual approaches to offering predictive testing for BRCA1/2 mutations in unaffected relatives.
Evans DG; Binchy A; Shenton A; Hopwood P; Craufurd D
Clin Genet; 2009 Feb; 75(2):124-32. PubMed ID: 19215246
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of acute and post-traumatic stress disorder and comorbid mental disorders in breast cancer patients during primary cancer care: a prospective study.
Mehnert A; Koch U
Psychooncology; 2007 Mar; 16(3):181-8. PubMed ID: 16856147
[TBL] [Abstract][Full Text] [Related]
26. Attitudes and psychological impact of genetic testing, genetic counseling, and breast cancer risk assessment among women at increased risk.
Hutson SP
Oncol Nurs Forum; 2003; 30(2):241-6. PubMed ID: 12692658
[TBL] [Abstract][Full Text] [Related]
27. Alterations in morning cortisol associated with PTSD in women with breast cancer.
Luecken LJ; Dausch B; Gulla V; Hong R; Compas BE
J Psychosom Res; 2004 Jan; 56(1):13-5. PubMed ID: 14987959
[TBL] [Abstract][Full Text] [Related]
28. A prospective study of the impact of genetic susceptibility testing for BRCA1/2 or HNPCC on family relationships.
van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Riedijk SR; van Dooren S; Tibben A
Psychooncology; 2007 Apr; 16(4):320-8. PubMed ID: 16909428
[TBL] [Abstract][Full Text] [Related]
29. Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.
Eisen A; Lubinski J; Klijn J; Moller P; Lynch HT; Offit K; Weber B; Rebbeck T; Neuhausen SL; Ghadirian P; Foulkes WD; Gershoni-Baruch R; Friedman E; Rennert G; Wagner T; Isaacs C; Kim-Sing C; Ainsworth P; Sun P; Narod SA
J Clin Oncol; 2005 Oct; 23(30):7491-6. PubMed ID: 16234515
[TBL] [Abstract][Full Text] [Related]
30. The prevalence of germline BRCA1 and BRCA2 mutations in young women with breast cancer undergoing breast-conservation therapy.
Golshan M; Miron A; Nixon AJ; Garber JE; Cash EP; Iglehart JD; Harris JR; Wong JS
Am J Surg; 2006 Jul; 192(1):58-62. PubMed ID: 16769276
[TBL] [Abstract][Full Text] [Related]
31. Severity of combat-related posttraumatic stress disorder versus noncombat-related posttraumatic stress disorder: a community-based study in American Indian and Hispanic veterans.
Brinker M; Westermeyer J; Thuras P; Canive J
J Nerv Ment Dis; 2007 Aug; 195(8):655-61. PubMed ID: 17700297
[TBL] [Abstract][Full Text] [Related]
32. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
33. Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.
van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; van Gool AR; Klijn JG; Tibben A
Clin Genet; 2007 Jan; 71(1):35-42. PubMed ID: 17204044
[TBL] [Abstract][Full Text] [Related]
34. Disease family history and modification of breast cancer risk in common BRCA2 variants.
Seymour IJ; Casadei S; Zampiga V; Rosato S; Danesi R; Falcini F; Strada M; Morini N; Naldoni C; Paradiso A; Tommasi S; Schittulli F; Amadori D; Calistri D
Oncol Rep; 2008 Mar; 19(3):783-6. PubMed ID: 18288416
[TBL] [Abstract][Full Text] [Related]
35. BRCA1 and BRCA2: the genetic testing and the current management options for mutation carriers.
Palma M; Ristori E; Ricevuto E; Giannini G; Gulino A
Crit Rev Oncol Hematol; 2006 Jan; 57(1):1-23. PubMed ID: 16337408
[TBL] [Abstract][Full Text] [Related]
36. [Mental disorders in general hospital patients].
Rothenhäusler HB
Psychiatr Danub; 2006 Dec; 18(3-4):183-92. PubMed ID: 17099609
[TBL] [Abstract][Full Text] [Related]
37. A gift or a yoke? Women's and men's responses to genetic risk information from BRCA1 and BRCA2 testing.
d'Agincourt-Canning L
Clin Genet; 2006 Dec; 70(6):462-72. PubMed ID: 17100990
[TBL] [Abstract][Full Text] [Related]
38. Living with the BRCA genetic mutation: an uncertain conclusion to an unending process.
DiMillo J; Samson A; Thériault A; Lowry S; Corsini L; Verma S; Tomiak E
Psychol Health Med; 2013; 18(2):125-34. PubMed ID: 22670560
[TBL] [Abstract][Full Text] [Related]
39. Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result.
Bonadona V; Saltel P; Desseigne F; Mignotte H; Saurin JC; Wang Q; Sinilnikova O; Giraud S; Freyer G; Plauchu H; Puisieux A; Lasset C
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):97-104. PubMed ID: 11815406
[TBL] [Abstract][Full Text] [Related]
40. Does "subthreshold" posttraumatic stress disorder have any clinical relevance?
Zlotnick C; Franklin CL; Zimmerman M
Compr Psychiatry; 2002; 43(6):413-9. PubMed ID: 12439826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
